“I shared ownership with the oncologist. It’s gonna require the patient to be brave enough to try it, and to have a doctor who is willing to support it.” - Bryce Olson See the entire Cancer Patient Lab session with Bryce Olson and Dr. Robert Gatenby at: https://youtu.be/WbhXk-3Wz4s Read the full transcript at: https://docs.google.com/document/d/1d-z_Gh7CRwoeALKP1Mty-1yrSYxDZGyvd1tz7F_Xvyg/edit?usp=sharing Join the Cancer Patient Lab at www.cancerpatientlab.org The information and opinions expressed on this website or platform, or during discussions and presentations (both verbal and written) are not intended as health care recommendations or medical advice by Cancer Patient Lab, its principals, presenters, participants, or representatives for any medical treatment, product, or course of action. You should always consult a doctor about your specific situation before pursuing any health care program, treatment, product or other course of action that might affect your health.

“Genes don't reliably predict response to treatment, and the gene mutations or expression in cells don't reliably predict the expression of proteins in our cancer cells… If we ever want to achieve precision oncology, we must figure out both on the science side and on the institutional side how to embrace diagnostics of many proteins, coupled with some genes or gene expression, and patient data.” Amanda Paulovich, MD, PhD, Fred Hutchinson Cancer Center

Filtricine is a biotech startup founded by researchers who came from Stanford to see if they could starve cancer cells with a restricted diet. They are developing a nutrient formulation which attempts to identify and exploit cancer cells’ metabolic vulnerabilities (the chemical processes that produce energy and basic materials needed for survival). Their diet eliminates some amino acids that cancer cells need but aren’t needed by normal cells.